AbbVie enlists protein degradation experts at Mission for a new bet on Alzheimer's, Parkinson's

As a group of preclinical biotechs focused on protein degradation steadily gathers steam, AbbVie is jumping on the bandwagon albeit steering it to a somewhat surprising direction: Alzheimer’s and Parkinson’s diseases.